272 related articles for article (PubMed ID: 32397324)
1. The Expression of microRNA in Adult Rat Heart with Isoproterenol-Induced Cardiac Hypertrophy.
Gan M; Zhang S; Fan Y; Tan Y; Guo Z; Chen L; Bai L; Jiang D; Hao X; Li X; Shen L; Zhu L
Cells; 2020 May; 9(5):. PubMed ID: 32397324
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA CHRF facilitates cardiac hypertrophy through regulating Akt3 via miR-93.
Wo Y; Guo J; Li P; Yang H; Wo J
Cardiovasc Pathol; 2018; 35():29-36. PubMed ID: 29747050
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling.
Yuan Y; Wang J; Chen Q; Wu Q; Deng W; Zhou H; Shen D
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1421-1427. PubMed ID: 30794866
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA expression in isoproterenol hydrochloride-induced cardiac hypertrophy.
Yang MH; Wang H; Han SN; Jia X; Zhang S; Dai FF; Zhou MJ; Yin Z; Wang TQ; Zang MX; Xue LX
Aging (Albany NY); 2020 Feb; 12(3):2530-2544. PubMed ID: 32023551
[TBL] [Abstract][Full Text] [Related]
6. Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin.
Zhou X; Sun F; Luo S; Zhao W; Yang T; Zhang G; Gao M; Lu R; Shu Y; Mu W; Zhuang Y; Ding F; Xu C; Lu Y
Int J Biol Sci; 2017; 13(1):22-31. PubMed ID: 28123343
[No Abstract] [Full Text] [Related]
7. Differential microRNA expression profiles and bioinformatics analysis between young and aging spontaneously hypertensive rats.
Wang J; Zhang J; Ding X; Wang Y; Li Z; Zhao W; Jia J; Zhou J; Ge J
Int J Mol Med; 2018 Mar; 41(3):1584-1594. PubMed ID: 29328372
[TBL] [Abstract][Full Text] [Related]
8. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
9. Egr-1 mediated cardiac miR-99 family expression diverges physiological hypertrophy from pathological hypertrophy.
Ramasamy S; Velmurugan G; Rekha B; Anusha S; Shanmugha Rajan K; Shanmugarajan S; Ramprasath T; Gopal P; Tomar D; Karthik KV; Verma SK; Garikipati VNS; Sudarsan R
Exp Cell Res; 2018 Apr; 365(1):46-56. PubMed ID: 29481791
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA FTX Reduces Hypertrophy of Neonatal Mouse Cardiac Myocytes and Regulates the PTEN/PI3K/Akt Signaling Pathway by Sponging MicroRNA-22.
Yang X; Tao L; Zhu J; Zhang S
Med Sci Monit; 2019 Dec; 25():9609-9617. PubMed ID: 31840653
[TBL] [Abstract][Full Text] [Related]
11.
Ming S; Shui-Yun W; Wei Q; Jian-Hui L; Ru-Tai H; Lei S; Mei J; Hui W; Ji-Zheng W
Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29440459
[TBL] [Abstract][Full Text] [Related]
12. DSCAM-AS1 mediates pro-hypertrophy role of GRK2 in cardiac hypertrophy aggravation via absorbing miR-188-5p.
Chen H; Cai K
In Vitro Cell Dev Biol Anim; 2020 Apr; 56(4):286-295. PubMed ID: 32377998
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA cardiac hypertrophy-associated regulator governs cardiac hypertrophy via regulating miR-20b and the downstream PTEN/AKT pathway.
Zhang M; Jiang Y; Guo X; Zhang B; Wu J; Sun J; Liang H; Shan H; Zhang Y; Liu J; Wang Y; Wang L; Zhang R; Yang B; Xu C
J Cell Mol Med; 2019 Nov; 23(11):7685-7698. PubMed ID: 31465630
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of miR-146b-5p alleviates isoprenaline-induced cardiac hypertrophy via regulating DFCP1.
Liu S; Su L; Li J; Zhang Y; Hu X; Wang P; Liu P; Ye J
Mol Cell Endocrinol; 2024 Aug; 589():112252. PubMed ID: 38649132
[TBL] [Abstract][Full Text] [Related]
15. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.
Wang K; Liu F; Zhou LY; Long B; Yuan SM; Wang Y; Liu CY; Sun T; Zhang XJ; Li PF
Circ Res; 2014 Apr; 114(9):1377-88. PubMed ID: 24557880
[TBL] [Abstract][Full Text] [Related]
16. AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway.
Hu X; Ou-Yang Q; Wang L; Li T; Xie X; Liu J
Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):20-30. PubMed ID: 30566571
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B
Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-339-5p promotes isoproterenol-induced cardiomyocyte hypertrophy by targeting VCP to activate the mTOR signaling.
Bi X; Zhang Y; Yu Y; Yuan J; Xu S; Liu F; Ye J; Liu P
Cell Biol Int; 2022 Feb; 46(2):288-299. PubMed ID: 34854520
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways.
Ge Y; Pan S; Guan D; Yin H; Fan Y; Liu J; Zhang S; Zhang H; Feng L; Wang Y; Xu R; Yin JQ
Biochim Biophys Acta; 2013 Jan; 1832(1):1-10. PubMed ID: 23000971
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA myocardial infarction‑associated transcript is associated with the microRNA‑150‑5p/P300 pathway in cardiac hypertrophy.
Li Z; Liu Y; Guo X; Sun G; Ma Q; Dai Y; Zhu G; Sun Y
Int J Mol Med; 2018 Sep; 42(3):1265-1272. PubMed ID: 29786749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
